<track id="pr77r"><strike id="pr77r"><ol id="pr77r"></ol></strike></track>
        <pre id="pr77r"></pre>

          <track id="pr77r"><strike id="pr77r"><ol id="pr77r"></ol></strike></track>

            <pre id="pr77r"></pre>
            Global EditionASIA 中文雙語Fran?ais
            Lifestyle
            Home / Lifestyle / Health

            Gilead Sciences participates in CIIE for first time, brings new products

            By Yuan Shenggao | China Daily | Updated: 2022-11-05 10:12
            Share
            Share - WeChat
            Gilead Sciences' booth at the fifth China International Import Expo.[Photo provided to China Daily]

            The fifth China International Import Expo, kicking off on Saturday, is offering great opportunities for internationally leading pharmaceutical company Gilead Sciences to showcase its new discoveries in virology, oncology and mycology sciences, the company said.

            This year marks the 35th anniversary of Gilead Sciences' establishment. With the vision of "creating a healthier world", the company has been committed to promoting drug innovation in a bid to treat diseases such as HIV, viral hepatitis and cancer.

            At its booth during the fair, the company is exhibiting a group of new launches in China, looking forward to setting up more partnerships to improve new drug accessibility and eliminate barriers for the public to pursue their well-being and health, and promote the construction of the"Healthy China 2030" initiative with joint efforts.

            Gilead Sciences launched China operations in 2017 in Shanghai. In recent years, it has grown from zero to a large-scale company with more than 600 employees. Nine of its products have been launched in the Chinese market and seven of them have entered the national reimbursement drug list. It has launched businesses across more than 80 cities in China.

            The CIIE is an excellent platform for a company to expand the opening-up scale, set up cooperative partnerships and achieve win-win results, the company said.

            The company is tapping into the field of oncology and mycology in China. So this is a good time to show their past achievements and more importantly, their future development plans, the company said.

            1 2 Next   >>|
            Most Popular
            Top
            BACK TO THE TOP
            English
            Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
            License for publishing multimedia online 0108263

            Registration Number: 130349
            FOLLOW US
             
            玩美丽的阿?

                <track id="pr77r"><strike id="pr77r"><ol id="pr77r"></ol></strike></track>
                  <pre id="pr77r"></pre>

                    <track id="pr77r"><strike id="pr77r"><ol id="pr77r"></ol></strike></track>

                      <pre id="pr77r"></pre>